AstraZeneca (Rights to Moventig in The EU, Iceland, Norway, Switzerland and Liechtenstein) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

AstraZeneca (Rights to Moventig in The EU, Iceland, Norway, Switzerland and Liechtenstein) General Information

Description

Rights to the development of a drug for opioid-induced constipation (OIC) treatment. The asset consists of the rights to sell and develop the drug in the European Union (EU), Iceland, Norway, Switzerland and Liechtenstein.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 2 Kingdom Street
  • London W2 6BD
  • England, United Kingdom
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Corporate Office
  • 2 Kingdom Street
  • London W2 6BD
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AstraZeneca (Rights to Moventig in The EU, Iceland, Norway, Switzerland and Liechtenstein) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AstraZeneca (Rights to Moventig in The EU, Iceland, Norway, Switzerland and Liechtenstein)‘s full profile, request access.

Request a free trial

AstraZeneca (Rights to Moventig in The EU, Iceland, Norway, Switzerland and Liechtenstein) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore AstraZeneca (Rights to Moventig in The EU, Iceland, Norway, Switzerland and Liechtenstein)‘s full profile, request access.

Request a free trial

AstraZeneca (Rights to Moventig in The EU, Iceland, Norway, Switzerland and Liechtenstein) FAQs

  • Where is AstraZeneca (Rights to Moventig in The EU, Iceland, Norway, Switzerland and Liechtenstein) headquartered?

    AstraZeneca (Rights to Moventig in The EU, Iceland, Norway, Switzerland and Liechtenstein) is headquartered in London, United Kingdom.

  • What industry is AstraZeneca (Rights to Moventig in The EU, Iceland, Norway, Switzerland and Liechtenstein) in?

    AstraZeneca (Rights to Moventig in The EU, Iceland, Norway, Switzerland and Liechtenstein)’s primary industry is Buildings and Property.

  • Is AstraZeneca (Rights to Moventig in The EU, Iceland, Norway, Switzerland and Liechtenstein) a private or public company?

    AstraZeneca (Rights to Moventig in The EU, Iceland, Norway, Switzerland and Liechtenstein) is a Private company.

  • What is the current valuation of AstraZeneca (Rights to Moventig in The EU, Iceland, Norway, Switzerland and Liechtenstein)?

    The current valuation of AstraZeneca (Rights to Moventig in The EU, Iceland, Norway, Switzerland and Liechtenstein) is .

  • What is AstraZeneca (Rights to Moventig in The EU, Iceland, Norway, Switzerland and Liechtenstein)’s current revenue?

    The current revenue for AstraZeneca (Rights to Moventig in The EU, Iceland, Norway, Switzerland and Liechtenstein) is .

  • Who are AstraZeneca (Rights to Moventig in The EU, Iceland, Norway, Switzerland and Liechtenstein)’s investors?

    AstraZeneca has invested in AstraZeneca (Rights to Moventig in The EU, Iceland, Norway, Switzerland and Liechtenstein).

  • When was AstraZeneca (Rights to Moventig in The EU, Iceland, Norway, Switzerland and Liechtenstein) acquired?

    AstraZeneca (Rights to Moventig in The EU, Iceland, Norway, Switzerland and Liechtenstein) was acquired on 01-Mar-2016.

  • Who acquired AstraZeneca (Rights to Moventig in The EU, Iceland, Norway, Switzerland and Liechtenstein)?

    AstraZeneca (Rights to Moventig in The EU, Iceland, Norway, Switzerland and Liechtenstein) was acquired by Kyowa Kirin International.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process